Anti-Human CXCL12 Recombinant Antibody (hu30D8) (CAT#: TAB-416CT)

Recombinant monoclonal antibody against mouse and human CXCL12α, CXCL12β, and CXCL12γ, was shown to dose-dependently block CXCL12α binding to CXCR4 and CXCR7, and CXCL12α-induced Jurkat cell migration in vitro.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Funcs

Figure 1 In vivo activity of hu30D8.

Figure 1 In vivo activity of hu30D8.

Dose-dependent efficacy of hu30D8 in the human Calu-6 tumor model. Balb c/nude mice (n = 10/group) were treated with hu30D8 at various doses, alone) or with 30 mg/kg hu30D8 in combination with 10 mg/kg B20.4.1.1. Tumor size was measured at day 7, 10, 14, 17, and 21.

Zhong, C., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., ... & Quintana, L. (2013). Development and preclinical characterization of a humanized antibody targeting CXCL12. Clinical Cancer Research, 19(16), 4433-4445.

FACS

Figure 2 In vivo activity of hu30D8.

Figure 2 In vivo activity of hu30D8.

Percentage of F4/80+, CD11b+/Gr1+, and CD31+ cells in Calu6 tumors treated with the control human antibody or hu30D8 at day 21 after tumor cell implantation using FACS. Data are expressed as means ± SD and are representative of 3 independent experiments.

Zhong, C., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., ... & Quintana, L. (2013). Development and preclinical characterization of a humanized antibody targeting CXCL12. Clinical Cancer Research, 19(16), 4433-4445.

PK

Figure 3 Pharmacokinetic profiles of hu30D8.

Figure 3 Pharmacokinetic profiles of hu30D8.

hu30D8 e serum concentration–time profiles in cynomolgus monkeys after a single intravenous administration at 30 mg/kg (n = 5/group). Sera were collected for up to 10 days.

Zhong, C., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., ... & Quintana, L. (2013). Development and preclinical characterization of a humanized antibody targeting CXCL12. Clinical Cancer Research, 19(16), 4433-4445.

ELISA

Figure 4 Pharmacokinetic profiles of hu30D8.

Figure 4 Pharmacokinetic profiles of hu30D8.

hu30D8 serum concentration showed in and was measured by a specific ELISA using human CXCL12α as a coating agent.

Zhong, C., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., ... & Quintana, L. (2013). Development and preclinical characterization of a humanized antibody targeting CXCL12. Clinical Cancer Research, 19(16), 4433-4445.


Specifications

  • Host Species
  • Humanized
  • Type
  • Humanized antibody
  • Specificity
  • Human
  • Species Reactivity
  • Mouse and Human CXCL12α, CXCL12β, and CXCL12γ
  • Clone
  • hu30D8
  • Applications
  • Funcs, FC, PK, ELISA, Neut, WB
  • Related Disease
  • Cancer and inflammation-related diseases

Applications

  • Application Notes
  • The CXCL12 antibody has been reported in applications of Functional Assay, Flow Cytometry, Pharmacokinetic, Enzyme-linked Immunosorbent Assay, Neutralization, Western Blot.

Target

  • Alternative Names
  • CXCL12; chemokine (C-X-C motif) ligand 12; IRH; PBSF; SDF1; TLSF; TPAR1; SCYB12; stromal cell-derived factor 1; intercrine reduced in hepatomas; pre-B cell growth-stimulating factor; anti-SDF-1

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone hu30D8"

See other products for "CXCL12"

Single-domain Antibody

Humanized Antibody

CAT Product Name Application Type
TAB-416CT-S(P) Anti-Human CXCL12 Recombinant Antibody scFv Fragment (hu30D8) WB, ELISA, Neut, FC Humanized antibody
TAB-416CT-F(E) Anti-Human CXCL12 Recombinant Antibody Fab Fragment (hu30D8) WB, ELISA, Neut, FC Humanized antibody

Neutralizing Antibody

CAT Product Name Application Type
NEUT-612CQ Mouse Anti-CXCL12 Recombinant Antibody (clone CBL825) Neut Mouse IgG1

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-0884 Hi-Affi™ Rabbit Anti-CXCL12 Recombinant Antibody (clone DS884AB) WB, ICC, IF Rabbit IgG

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-416CT. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare